Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia
Public ClinicalTrials.gov record NCT06111027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Usability of Laryngeal Vibro-tactile Stimulation as a Non-invasive Treatment for the Voice Disorder Spasmodic Dysphonia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The general aim of the study was to provide evidence for the usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (laryngeal dystonia). This work addresses a clinical need to develop alternative or auxiliary treatments for a rare voice disorder with limited treatment options.
Study identification
- NCT ID
- NCT06111027
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2023
- Primary completion
- Oct 27, 2024
- Completion
- Oct 30, 2024
- Last update posted
- Jul 14, 2026
2023 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55414 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Spasmodic Dysphonia trials
Other public records listing Spasmodic Dysphonia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07041203: Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor Not yet recruiting
- NCT03042962: Brain Networks in Dystonia Recruiting
- NCT05216770: Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor Recruiting
- NCT05150106: Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor Recruiting
- NCT05150093: Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor Recruiting
- NCT06078527: Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06111027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06111027 live on ClinicalTrials.gov.